Press Releases

Jul 24, 2019
Bicycle Therapeutics Enhances Board of Directors
Appoints pharmaceutical industry veteran Richard N. Kender , MBA, and life sciences financing professional Janice Bourque , MBA Orderly transition planned for four board members to depart over the next 12 months CAMBRIDGE, England & BOSTON --(BUSINESS WIRE)--Jul.
May 22, 2019
Bicycle Therapeutics Announces Pricing of Initial Public Offering
CAMBRIDGE, England & BOSTON --(BUSINESS WIRE)--May 22, 2019-- Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide ( Bicycle® ) product platform, today announced the pricing of its initial public offering
May 09, 2019
Bicycle Therapeutics Strengthens Clinical Team to Advance Expanding Pipeline
CAMBRIDGE, U.K., and BOSTON, Mass., May 9, 2019 –  Bicycle Therapeutics , a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide ( Bicycle ® ) product platform, today announced two senior appointments to facilitate its expanding and advancing
Displaying 1 - 10 of 19